FMT for recurrent C. difficile (RCT)

Layer 3 — Biologyin the Host-Microbiome subtree

van Nood et al 2013 NEJM; randomised trial of FMT vs vancomycin for recurrent C. difficile colitis; 81% vs 31% cure; trial halted early for efficacy.

Related concepts

Explore FMT for recurrent C. difficile (RCT) on the interactive knowledge graph →